Search results
- This guarantees funding levels until 2023/24 and sets out how pharmacies will adapt to provide new services to help people to stay healthy and prevent illness; to support and provide urgent care services; to support people leaving hospital; and to help people avoid unnecessary visits to GPs and hospitals.
cpe.org.uk/learn-more-about-community-pharmacy/what-pharmacies-do/
People also ask
Why should pharmacies be able to provide new services in 2023/24?
What is the new NHS community pharmacy consultation service?
Will community pharmacy be a part of the NHS?
Will pharmacies offer more services to patients?
When will DHSC announce a five-year community pharmacy contractual framework deal?
Why should community pharmacy invest in the NHS long term plan?
Jul 11, 2023 · This document replaces guidance issued for all previous schemes and provides further detail for contractors regarding how they demonstrate compliance with this year’s scheme requirements. The 2023/24 PQS consists of one gateway criterion and three quality domains.
Sep 22, 2022 · Pharmacies to offer more services. Health secretary Dr Thérèse Coffey’s Our Plan for Patients published earlier today revealed plans to expand the range of services available from community pharmacies and for pharmacies to be able to manage and supply more medicines without a prescription from a GP, such as contraception.
Feb 10, 2022 · This guarantees funding levels until 2023/24 and sets out how pharmacies will adapt to provide new services to help people to stay healthy and prevent illness; to support and provide urgent care services; to support people leaving hospital; and to help people avoid unnecessary visits to GPs and hospitals.
Framework will enable community pharmacy to supply some POMs for 7 common conditions without need for a GP appointment & prescription. It also proposes to expand existing BP checks and oral contraception services. Together, these could free up 10 million GP appointments/year.
- Delivery plan for recovering access to primary care
- New and expanded services
- Year 5 Pharmacy Quality Scheme (PQS) 2023 to 2024
- Funding
- VAT
- Concessionary price review
- Reimbursement reforms
- Original pack dispensing and medicines containing sodium valproate
- Medicine margin
On 9 May, the Delivery plan for recovering access to primary care was published. As part of this plan, a further investment of up to £645 million over 2 years was announced. This is to expand the role of community pharmacy by supporting 7 further common conditions and also expanding the pharmacy oral contraception and blood pressure services. The n...
On 24 April, Tier 1 of the NHS Pharmacy Contraception Service was launched. This new service enables community pharmacists to provide ongoing management, via a patient group direction (PGD), of routine oral contraception that was initiated in general practice or by a sexual health clinic.
On 15 May 2023, the Community Pharmacist Consultation Service will be expanded to enable urgent and emergency care settings to refer patients to a community pharmacist for a consultation for minor illness or urgent medicine supply.
The pilot to expand the New Medicines Service (NMS) to include antidepressants is underway and a further update on the expansion of the existing service will be provided in due course.
We remain committed to the 4 October 2023 launch date, to introduce Tier 2 of the NHS Pharmacy Contraception Service, subject to a positive evaluation of the pilot. This will enable community pharmacists to also initiate oral contraception, via a PGD, and provide ongoing clinical checks and annual reviews.
From 1 April 2023, to recognise the valuable skill mix that exists in community pharmacy, the service specifications for the Blood Pressure Check Service and Smoking Cessation Service have been amended to also allow delivery by pharmacy technicians. Other services or elements of services that may be deliverable by pharmacy technicians will continue to be reviewed.
Following the announcement in the Spring Budget 2023 about forthcoming changes to extend the VAT exemption for healthcare to include services carried out by staff directly supervised by registered pharmacy professionals, we will review service specifications to enable delivery by non-registered staff under supervision.
Year 5 gateway and quality criteria
Gateway criteria: 15 NMSs between 1 April 2023 and the end of 31 December 2023. Quality criteria: reducing harm from anticoagulants – re-audit and implementation of learnings and recommendations from 2021 to 2022 audit palliative and end-of-life care – as per year 4 requirements respiratory – as per year 4 requirements antimicrobial stewardship – as per year 3 and year 4 requirements plus advice on safe disposal of unused or expired antibiotics
The transitional payment was set at £0 in February 2023. The monthly payment of a flat fee started in April 2023 to all pharmacy contractors who dispense at least 101 items a month up to a national total of £70 million on an annual basis. This amount is subject to change if clinical service volumes grow beyond our forecasts and all unallocated fund...
As announced in the Spring Budget 2023, the government will legislate by Statutory Instrument to extend the VAT exemption for healthcare to include services carried out by staff directly supervised by registered pharmacists in the UK. The changes came into effect on 1 May 2023.
As announced in the Spring Budget 2023, the government will extend the zero rate of VAT on prescriptions to medicines supplied through PGDs. This measure will be introduced in autumn 2023.
Following the review of the concessionary price process, from April 2023 products granted a concessionary price are classified as ‘discount not deducted’ (DND) for the month(s) they are on concession. Furthermore, for products requested after the 23rd of the month, the concessionary price granted can be rolled over to the following month. We are co...
Discount deduction arrangements
The transition to the new discount deduction arrangements is progressing but we will continue to monitor the implementation. While the intent is to rely on the margin survey to adjust for any increased or decreased delivery of margin, we may need to consider other adjustments, for example applying a tolerance level where adjustments to discount rates need to be applied, to reduce the impact on margin delivery.
Category A
Following feedback from PSNC on DHSC’s proposals to base the reimbursement prices of generic medicines in category A on market sales and volumes data, we are looking to implement this in summer 2023.
Remainder of proposals
DHSC remains committed to continuing to work with PSNC on the remainder of the proposals set out in the reimbursement reforms consultation response.
Following the publication of the consultation response on Original pack dispensing and medicines containing sodium valproate, DHSC will progress the amendments to the Human Medicines Regulations 2012. In line with this we will need to work with PSNC firstly to accommodate full pack dispensing and reimbursement of sodium valproate prescriptions and ...
As part of the delivery of the additional investment into funding of the Community Pharmacy Contractual Framework during years 4 and 5, category M reimbursement prices have received an upward adjustment since October 2022, with the aim of delivering the agreed £100 million by October 2023.
The results of the medicine margin survey have shown an over-delivery of medicine margin up to April 2022. Alongside the additional £100 million, category M reimbursement prices have been adjusted on a quarterly basis to recoup this over-delivery which is projected to have finished by April 2024.
how the role of pharmacies could be expanded in primary care and how the commissioning of a fully funded Pharmacy First service, would allow patients to have walk-in consultations for minor conditions and could provide accessible care and ease pressure on general practice.
Foremost amongst the new services is the new national NHS Community Pharmacist Consultation Service, connecting patients who have a minor illness with a community pharmacy which should rightly be their first port of call.
